Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 359

    1.

    Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.

    Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Ménard HA.

    Arthritis Res Ther. 2005;7(3):R592-603. Epub 2005 Mar 17.

    PMID:
    15899046
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.

    Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Ménard HA, Boire G.

    Arthritis Rheum. 2009 Mar;60(3):698-707.

    PMID:
    19248090
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodies.

    Guzian MC, Carrier N, Cossette P, de Brum-Fernandes AJ, Liang P, Ménard HA, Boire G.

    Arthritis Care Res (Hoboken). 2010 Nov;62(11):1624-32. doi: 10.1002/acr.20288. Epub 2010 Jul 8.

    PMID:
    20617532
    [PubMed - indexed for MEDLINE]
    4.

    Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.

    Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, Nicaise-Roland P, Sibilia J, Combe B.

    Ann Rheum Dis. 2003 Feb;62(2):120-6.

    PMID:
    12525380
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.

    van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW.

    Arthritis Rheum. 2004 Mar;50(3):709-15.

    PMID:
    15022309
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.

    Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S.

    Ann Rheum Dis. 2006 Apr;65(4):453-8. Epub 2005 Sep 21.

    PMID:
    16176994
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.

    Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Ménard HA, Zhou ZJ, Palosuo T, Van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HR Jr, El-Gabalawy HS.

    Arthritis Res. 2000;2(3):236-43. Epub 2000 Mar 31.

    PMID:
    11056669
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.

    Meyer O, Nicaise-Roland P, Santos MD, Labarre C, Dougados M, Goupille P, Cantagrel A, Sibilia J, Combe B.

    Arthritis Res Ther. 2006;8(2):R40. Epub 2006 Jan 26.

    PMID:
    16469118
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.

    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.

    Arthritis Rheum. 2009 Aug;60(8):2232-41.

    PMID:
    19644872
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.

    Mathsson L, Mullazehi M, Wick MC, Sjöberg O, van Vollenhoven R, Klareskog L, Rönnelid J.

    Arthritis Rheum. 2008 Jan;58(1):36-45.

    PMID:
    18163519
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.

    Mewar D, Coote A, Moore DJ, Marinou I, Keyworth J, Dickson MC, Montgomery DS, Binks MH, Wilson AG.

    Arthritis Res Ther. 2006;8(4):R128.

    PMID:
    16859535
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.

    van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW.

    Arthritis Res Ther. 2005;7(5):R949-58. Epub 2005 Jun 14.

    PMID:
    16207336
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

    Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B; BARFOT Study Group.

    Ann Rheum Dis. 2004 Sep;63(9):1090-5.

    PMID:
    15308518
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis.

    Jansen LM, van Schaardenburg D, van der Horst-Bruinsma I, van der Stadt RJ, de Koning MH, Dijkmans BA.

    J Rheumatol. 2003 Aug;30(8):1691-5.

    PMID:
    12913923
    [PubMed - indexed for MEDLINE]
    15.

    Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project.

    Svärd A, Kastbom A, Reckner-Olsson A, Skogh T.

    Arthritis Res Ther. 2008;10(4):R75. Epub 2008 Jul 4.

    PMID:
    18601717
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.

    Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Smolen JS, Steiner G.

    Ann Rheum Dis. 2005 Dec;64(12):1731-6. Epub 2005 May 5.

    PMID:
    15878904
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Role of anti cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis.

    Shankar S, Grover R, Handa R.

    Indian J Med Res. 2006 Dec;124(6):689-96.

    PMID:
    17287557
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.

    Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA.

    J Rheumatol. 2002 Oct;29(10):2074-6.

    PMID:
    12375314
    [PubMed - indexed for MEDLINE]
    20.

    Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.

    Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.

    J Rheumatol. 2006 Dec;33(12):2390-7. Epub 2006 Aug 15.

    PMID:
    16924694
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk